Dr. Ethan Blake Nelson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 103 Mark Dr, Edenton, NC 27932 Phone: 252-482-5131 |
Dr. Jerry L Bradley, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 512 Coke Avenue, Edenton, NC 27932 Phone: 252-482-1080 Fax: 252-482-1082 |
Paul Stephen Richmond, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 410 N Broad Street, Edenton, NC 27932 Phone: 252-482-2181 |
Dr. Jalisa B. Parrish, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 512 Coke Ave, Edenton, NC 27932 Phone: 252-482-1080 Fax: 252-482-1082 |
Dr. Lonnie V Sieck, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 103 Mark Dr, Edenton, NC 27932 Phone: 252-482-5105 Fax: 252-482-5587 |
Dr. Christopher Haley Koppelman, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 103 Mark Dr, Edenton, NC 27932 Phone: 252-482-5131 Fax: 252-482-5587 |
News Archive
Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly (STMS) publishing business of John Wiley & Sons, Inc. is pleased to announce a new partnership with The Hastings Center, to publish the Hastings Center Report, one of the leading journals in the field of bioethics.
Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.
Should whole-genome sequencing be used in the public-health programs that screen newborns for rare conditions?
Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say.
IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.
› Verified 2 days ago